Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage

Edaravone dexborneol is a novel neuroprotective drug that comprises edaravone and (+)-borneol in a 4:1 ratio. Phase II and III studies have demonstrated that Chinese patients treated with edaravone dexborneol within 48 h of AIS onset have better functional outcomes than those treated with edaravone alone. However, the effect of edaravone dexborneol on subarachnoid hemorrhage (SAH) has not yet been elucidated. This study aimed to investigate the therapeutic effects of edaravone dexborneol on SAH-induced brain injury and long-term behavioral deficits and to explore the possible mechanisms. The experimental rat SAH model was induced by an intraluminal puncture of the left middle cerebral artery (MCA). Edaravone dexborneol or edaravone at a clinical dose was infused into the tail vein for 3 days post-SAH surgery. Behavioral outcomes were assessed by a modified Garcia scoring system and rotarod, foot-fault, and corner tests. Immunofluorescence, Western blot, and ELISA methods were used to evaluate neuronal damage and oxidative stress. Our results showed that a post-SAH therapeutic regimen with edaravone dexborneol helped improve neurological function up to 21 days after SAH surgery and demonstrated a greater beneficial effect than edaravone alone, accompanied by an obvious inhibition of neuronal apoptosis in the CA1 hippocampus and basal cortex regions. Mechanistically, edaravone dexborneol not only suppressed the lipid peroxidation product malondialdehyde (MDA) but also improved the total antioxidant capability (TAC) 3 days after SAH. Notably, edaravone dexborneol treatment significantly inhibited the expression of another lipid peroxidation product, 4-hydroxynonenal (4-HNE), in the CA1 hippocampus and basal cortex, which are vital participants in the process of neuronal oxidative damage and death after SAH because of their acute cytotoxicity. Together, our results demonstrate that edaravone dexborneol confers neuroprotection and stabilizes long-term behavioral ability after SAH injury, possibly by suppressing 4-HNE-associated oxidative stress. These results may help develop new clinical strategies for SAH treatment.

[1]  R. Zhan,et al.  Inflammation and Oxidative Stress: Potential Targets for Improving Prognosis After Subarachnoid Hemorrhage , 2021, Frontiers in Cellular Neuroscience.

[2]  Jian Wang,et al.  Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review , 2021, Frontiers in Pharmacology.

[3]  Yilong Wang,et al.  Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke , 2021, Stroke.

[4]  Leilei Mao,et al.  Low-Dose IL-2 Treatment Affords Protection against Subarachnoid Hemorrhage Injury by Expanding Peripheral Regulatory T Cells. , 2021, ACS chemical neuroscience.

[5]  Wenchao Liu,et al.  Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome , 2021, Frontiers in Pharmacology.

[6]  Hong Liu,et al.  Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity , 2021, Frontiers in Pharmacology.

[7]  Leilei Mao,et al.  Ethyl pyruvate improves white matter remodeling in rats after traumatic brain injury , 2020, CNS neuroscience & therapeutics.

[8]  Leilei Mao,et al.  The novel Nrf2 activator CDDO‐EA attenuates cerebral ischemic injury by promoting microglia/macrophage polarization toward M2 phenotype in mice , 2020, CNS neuroscience & therapeutics.

[9]  W. Guo,et al.  Bakuchiol Attenuates Oxidative Stress and Neuron Damage by Regulating Trx1/TXNIP and the Phosphorylation of AMPK After Subarachnoid Hemorrhage in Mice , 2020, Frontiers in Pharmacology.

[10]  J. Kochanowicz,et al.  Clinical Prognosis for SAH Consistent with Redox Imbalance and Lipid Peroxidation , 2020, Molecules.

[11]  Xiao-Xin Yan,et al.  Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats , 2020, Frontiers in Neuroscience.

[12]  A. Sudo,et al.  Protective Effect of Edaravone Against Oxidative Stress in C2C12 Myoblast and Impairment of Skeletal Muscle Regeneration Exposed to Ischemic Injury in Ob/ob Mice , 2020, Frontiers in Physiology.

[13]  Ming-feng Yang,et al.  Selective mGluR1 Negative Allosteric Modulator Reduces Blood–Brain Barrier Permeability and Cerebral Edema After Experimental Subarachnoid Hemorrhage , 2019, Translational Stroke Research.

[14]  Y. Porozov,et al.  Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases , 2019, Oxidative medicine and cellular longevity.

[15]  Yilong Wang,et al.  Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial , 2019, Stroke and Vascular Neurology.

[16]  Masato Naraoka,et al.  The Role of Oxidative Stress in Microvascular Disturbances after Experimental Subarachnoid Hemorrhage , 2019, Translational Stroke Research.

[17]  John H. Zhang,et al.  AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats , 2018, Redox biology.

[18]  Sheng Chen,et al.  The Updated Role of Oxidative Stress in Subarachnoid Hemorrhage. , 2017, Current drug delivery.

[19]  D. Tsikas Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. , 2017, Analytical biochemistry.

[20]  R. L. Macdonald,et al.  Spontaneous subarachnoid haemorrhage , 2017, The Lancet.

[21]  Lin Guo,et al.  4‐Hydroxynonenal Regulates TNF‐α Gene Transcription Indirectly via ETS1 and microRNA‐29b in Human Adipocytes Induced From Adipose Tissue‐Derived Stromal Cells , 2016, Anatomical record.

[22]  R. Lockey,et al.  4-Hydroxy-2-nonenal: a critical target in oxidative stress? , 2016, American journal of physiology. Cell physiology.

[23]  Ying Tang,et al.  The synergetic effect of edaravone and borneol in the rat model of ischemic stroke. , 2014, European journal of pharmacology.

[24]  Antonio Ayala,et al.  Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.

[25]  G. Mead,et al.  Edaravone Improves Functional and Structural Outcomes in Animal Models of Focal Cerebral Ischemia: A Systematic Review , 2014, International journal of stroke : official journal of the International Stroke Society.

[26]  M. Morioka,et al.  The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease , 2013, International journal of molecular sciences.

[27]  J. Mocco,et al.  Nitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment , 2013, Neurology research international.

[28]  N. Žarković,et al.  Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation , 2013, Free radical research.

[29]  John H. Zhang,et al.  The importance of early brain injury after subarachnoid hemorrhage , 2012, Progress in Neurobiology.

[30]  Akira Munakata,et al.  Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. , 2011, Acta neurochirurgica. Supplement.

[31]  K. Abe,et al.  Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. , 2010, Current neurovascular research.

[32]  M. Imano,et al.  Edaravone Protects Against Apoptotic Neuronal Cell Death and Improves Cerebral Function After Traumatic Brain Injury in Rats , 2010, Neurochemical Research.

[33]  S. Strack,et al.  Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. , 2009, Chemical research in toxicology.

[34]  Masato Naraoka,et al.  EFFECT OF A FREE RADICAL SCAVENGER, EDARAVONE, IN THE TREATMENT OF PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE , 2009, Neurosurgery.

[35]  John H. Zhang,et al.  A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model , 2008, Journal of Neuroscience Methods.

[36]  John H. Zhang,et al.  Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. , 2008, Acta neurochirurgica. Supplement.

[37]  G. Rinkel,et al.  Subarachnoid haemorrhage , 2006, BMJ : British Medical Journal.